nodes	percent_of_prediction	percent_of_DWPC	metapath
Hyoscyamine—CHRM1—Circadian rythm related genes—CARTPT—acquired immunodeficiency syndrome	0.000991	0.0274	CbGpPWpGaD
Hyoscyamine—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.000988	0.00103	CcSEcCtD
Hyoscyamine—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.000987	0.00102	CcSEcCtD
Hyoscyamine—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.000986	0.00102	CcSEcCtD
Hyoscyamine—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000976	0.00101	CcSEcCtD
Hyoscyamine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000975	0.00101	CcSEcCtD
Hyoscyamine—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000973	0.00101	CcSEcCtD
Hyoscyamine—Tension—Lamivudine—acquired immunodeficiency syndrome	0.000969	0.00101	CcSEcCtD
Hyoscyamine—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000968	0.001	CcSEcCtD
Hyoscyamine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000968	0.001	CcSEcCtD
Hyoscyamine—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000967	0.001	CcSEcCtD
Hyoscyamine—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000966	0.001	CcSEcCtD
Hyoscyamine—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000965	0.001	CcSEcCtD
Hyoscyamine—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000965	0.001	CcSEcCtD
Hyoscyamine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000965	0.001	CcSEcCtD
Hyoscyamine—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000964	0.001	CcSEcCtD
Hyoscyamine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00096	0.000996	CcSEcCtD
Hyoscyamine—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.000959	0.000995	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000959	0.000995	CcSEcCtD
Hyoscyamine—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000957	0.000993	CcSEcCtD
Hyoscyamine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000957	0.000993	CcSEcCtD
Hyoscyamine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000951	0.000987	CcSEcCtD
Hyoscyamine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000951	0.000987	CcSEcCtD
Hyoscyamine—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000951	0.000987	CcSEcCtD
Hyoscyamine—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.00095	0.000986	CcSEcCtD
Hyoscyamine—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000949	0.000985	CcSEcCtD
Hyoscyamine—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000949	0.000984	CcSEcCtD
Hyoscyamine—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000945	0.00098	CcSEcCtD
Hyoscyamine—Rash—Didanosine—acquired immunodeficiency syndrome	0.000943	0.000978	CcSEcCtD
Hyoscyamine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000942	0.000978	CcSEcCtD
Hyoscyamine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000942	0.000977	CcSEcCtD
Hyoscyamine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000937	0.000972	CcSEcCtD
Hyoscyamine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000936	0.000971	CcSEcCtD
Hyoscyamine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000935	0.00097	CcSEcCtD
Hyoscyamine—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000934	0.000968	CcSEcCtD
Hyoscyamine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000933	0.000968	CcSEcCtD
Hyoscyamine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000932	0.000967	CcSEcCtD
Hyoscyamine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000932	0.000966	CcSEcCtD
Hyoscyamine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.00093	0.000965	CcSEcCtD
Hyoscyamine—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.00093	0.000965	CcSEcCtD
Hyoscyamine—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000928	0.000963	CcSEcCtD
Hyoscyamine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000926	0.000961	CcSEcCtD
Hyoscyamine—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000924	0.000959	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000923	0.000957	CcSEcCtD
Hyoscyamine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000922	0.000956	CcSEcCtD
Hyoscyamine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00092	0.000955	CcSEcCtD
Hyoscyamine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000919	0.000953	CcSEcCtD
Hyoscyamine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000918	0.000952	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000917	0.000952	CcSEcCtD
Hyoscyamine—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000915	0.00095	CcSEcCtD
Hyoscyamine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000912	0.000946	CcSEcCtD
Hyoscyamine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.00091	0.000944	CcSEcCtD
Hyoscyamine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000905	0.000939	CcSEcCtD
Hyoscyamine—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000905	0.000939	CcSEcCtD
Hyoscyamine—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000902	0.000936	CcSEcCtD
Hyoscyamine—Pain—Indinavir—acquired immunodeficiency syndrome	0.000898	0.000931	CcSEcCtD
Hyoscyamine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000898	0.000931	CcSEcCtD
Hyoscyamine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000897	0.000931	CcSEcCtD
Hyoscyamine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000897	0.00093	CcSEcCtD
Hyoscyamine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000897	0.00093	CcSEcCtD
Hyoscyamine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000895	0.000929	CcSEcCtD
Hyoscyamine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000892	0.000926	CcSEcCtD
Hyoscyamine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000892	0.000926	CcSEcCtD
Hyoscyamine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000891	0.000925	CcSEcCtD
Hyoscyamine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000888	0.000922	CcSEcCtD
Hyoscyamine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000888	0.000922	CcSEcCtD
Hyoscyamine—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000887	0.00092	CcSEcCtD
Hyoscyamine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000887	0.00092	CcSEcCtD
Hyoscyamine—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000885	0.000918	CcSEcCtD
Hyoscyamine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000885	0.000918	CcSEcCtD
Hyoscyamine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000884	0.000917	CcSEcCtD
Hyoscyamine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000882	0.000915	CcSEcCtD
Hyoscyamine—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000881	0.000914	CcSEcCtD
Hyoscyamine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000878	0.000911	CcSEcCtD
Hyoscyamine—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000877	0.00091	CcSEcCtD
Hyoscyamine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000875	0.000908	CcSEcCtD
Hyoscyamine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000873	0.000906	CcSEcCtD
Hyoscyamine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000868	0.0009	CcSEcCtD
Hyoscyamine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000865	0.000897	CcSEcCtD
Hyoscyamine—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000863	0.000896	CcSEcCtD
Hyoscyamine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000862	0.000894	CcSEcCtD
Hyoscyamine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000861	0.000894	CcSEcCtD
Hyoscyamine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000859	0.000891	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000858	0.00089	CcSEcCtD
Hyoscyamine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000858	0.00089	CcSEcCtD
Hyoscyamine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000856	0.000888	CcSEcCtD
Hyoscyamine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000855	0.000887	CcSEcCtD
Hyoscyamine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000855	0.000887	CcSEcCtD
Hyoscyamine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000855	0.000887	CcSEcCtD
Hyoscyamine—CHRM3—GPCRs, Other—ACKR1—acquired immunodeficiency syndrome	0.000855	0.0237	CbGpPWpGaD
Hyoscyamine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000852	0.000883	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000848	0.00088	CcSEcCtD
Hyoscyamine—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000848	0.00088	CcSEcCtD
Hyoscyamine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000848	0.00088	CcSEcCtD
Hyoscyamine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000848	0.00088	CcSEcCtD
Hyoscyamine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000847	0.000879	CcSEcCtD
Hyoscyamine—CHRM2—GPCRs, Other—ACKR1—acquired immunodeficiency syndrome	0.000846	0.0234	CbGpPWpGaD
Hyoscyamine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000846	0.000878	CcSEcCtD
Hyoscyamine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000846	0.000878	CcSEcCtD
Hyoscyamine—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000845	0.000876	CcSEcCtD
Hyoscyamine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000844	0.000875	CcSEcCtD
Hyoscyamine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000843	0.000874	CcSEcCtD
Hyoscyamine—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.00084	0.000872	CcSEcCtD
Hyoscyamine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000838	0.000869	CcSEcCtD
Hyoscyamine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000835	0.000867	CcSEcCtD
Hyoscyamine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000834	0.000865	CcSEcCtD
Hyoscyamine—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000831	0.000862	CcSEcCtD
Hyoscyamine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.00083	0.000861	CcSEcCtD
Hyoscyamine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00083	0.000861	CcSEcCtD
Hyoscyamine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000828	0.000859	CcSEcCtD
Hyoscyamine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000826	0.000857	CcSEcCtD
Hyoscyamine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000822	0.000853	CcSEcCtD
Hyoscyamine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000821	0.000852	CcSEcCtD
Hyoscyamine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00082	0.000851	CcSEcCtD
Hyoscyamine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.00082	0.000851	CcSEcCtD
Hyoscyamine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000819	0.000849	CcSEcCtD
Hyoscyamine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000818	0.000849	CcSEcCtD
Hyoscyamine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000818	0.000849	CcSEcCtD
Hyoscyamine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000817	0.000848	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000816	0.000847	CcSEcCtD
Hyoscyamine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000816	0.000847	CcSEcCtD
Hyoscyamine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000813	0.000844	CcSEcCtD
Hyoscyamine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000813	0.000844	CcSEcCtD
Hyoscyamine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000812	0.000843	CcSEcCtD
Hyoscyamine—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000811	0.000842	CcSEcCtD
Hyoscyamine—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000811	0.000842	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000811	0.000841	CcSEcCtD
Hyoscyamine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00081	0.00084	CcSEcCtD
Hyoscyamine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000807	0.000837	CcSEcCtD
Hyoscyamine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000806	0.000836	CcSEcCtD
Hyoscyamine—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000806	0.000836	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000806	0.000836	CcSEcCtD
Hyoscyamine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000801	0.000831	CcSEcCtD
Hyoscyamine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000799	0.000829	CcSEcCtD
Hyoscyamine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000798	0.000828	CcSEcCtD
Hyoscyamine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000794	0.000823	CcSEcCtD
Hyoscyamine—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000793	0.000822	CcSEcCtD
Hyoscyamine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000789	0.000819	CcSEcCtD
Hyoscyamine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000788	0.000817	CcSEcCtD
Hyoscyamine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000784	0.000813	CcSEcCtD
Hyoscyamine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000784	0.000813	CcSEcCtD
Hyoscyamine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000782	0.000812	CcSEcCtD
Hyoscyamine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000782	0.000811	CcSEcCtD
Hyoscyamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000781	0.0216	CbGpPWpGaD
Hyoscyamine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.00078	0.000809	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000779	0.000808	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000776	0.000805	CcSEcCtD
Hyoscyamine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000774	0.000803	CcSEcCtD
Hyoscyamine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000773	0.000802	CcSEcCtD
Hyoscyamine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000772	0.000801	CcSEcCtD
Hyoscyamine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000772	0.000801	CcSEcCtD
Hyoscyamine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000771	0.0008	CcSEcCtD
Hyoscyamine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000764	0.000792	CcSEcCtD
Hyoscyamine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00076	0.000788	CcSEcCtD
Hyoscyamine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000756	0.000785	CcSEcCtD
Hyoscyamine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000754	0.000782	CcSEcCtD
Hyoscyamine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000753	0.000781	CcSEcCtD
Hyoscyamine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000753	0.000781	CcSEcCtD
Hyoscyamine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000753	0.000781	CcSEcCtD
Hyoscyamine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000751	0.000779	CcSEcCtD
Hyoscyamine—Pain—Ritonavir—acquired immunodeficiency syndrome	0.00075	0.000778	CcSEcCtD
Hyoscyamine—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.00075	0.000778	CcSEcCtD
Hyoscyamine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.00075	0.000778	CcSEcCtD
Hyoscyamine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.00075	0.000778	CcSEcCtD
Hyoscyamine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000746	0.000774	CcSEcCtD
Hyoscyamine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000743	0.000771	CcSEcCtD
Hyoscyamine—CHRM4—Regulation of Actin Cytoskeleton—ACTG1—acquired immunodeficiency syndrome	0.000743	0.0206	CbGpPWpGaD
Hyoscyamine—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000743	0.00077	CcSEcCtD
Hyoscyamine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000731	0.000758	CcSEcCtD
Hyoscyamine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000729	0.000756	CcSEcCtD
Hyoscyamine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000728	0.000755	CcSEcCtD
Hyoscyamine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000723	0.00075	CcSEcCtD
Hyoscyamine—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000722	0.000749	CcSEcCtD
Hyoscyamine—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000722	0.000749	CcSEcCtD
Hyoscyamine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000718	0.000745	CcSEcCtD
Hyoscyamine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000718	0.000745	CcSEcCtD
Hyoscyamine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000718	0.000744	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000718	0.000744	CcSEcCtD
Hyoscyamine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000716	0.000743	CcSEcCtD
Hyoscyamine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000712	0.000738	CcSEcCtD
Hyoscyamine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000712	0.000738	CcSEcCtD
Hyoscyamine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000711	0.000738	CcSEcCtD
Hyoscyamine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000709	0.000736	CcSEcCtD
Hyoscyamine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000707	0.000734	CcSEcCtD
Hyoscyamine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000702	0.000728	CcSEcCtD
Hyoscyamine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000699	0.000725	CcSEcCtD
Hyoscyamine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000697	0.000723	CcSEcCtD
Hyoscyamine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000696	0.000722	CcSEcCtD
Hyoscyamine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000695	0.000721	CcSEcCtD
Hyoscyamine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000694	0.00072	CcSEcCtD
Hyoscyamine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000694	0.00072	CcSEcCtD
Hyoscyamine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000694	0.00072	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000691	0.000716	CcSEcCtD
Hyoscyamine—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000689	0.000715	CcSEcCtD
Hyoscyamine—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000689	0.000715	CcSEcCtD
Hyoscyamine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000681	0.000706	CcSEcCtD
Hyoscyamine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000679	0.000704	CcSEcCtD
Hyoscyamine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000671	0.000696	CcSEcCtD
Hyoscyamine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000671	0.000696	CcSEcCtD
Hyoscyamine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00067	0.000695	CcSEcCtD
Hyoscyamine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000668	0.000693	CcSEcCtD
Hyoscyamine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000668	0.000693	CcSEcCtD
Hyoscyamine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000667	0.000692	CcSEcCtD
Hyoscyamine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000664	0.000689	CcSEcCtD
Hyoscyamine—Rash—Indinavir—acquired immunodeficiency syndrome	0.000662	0.000687	CcSEcCtD
Hyoscyamine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000661	0.000686	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000659	0.000683	CcSEcCtD
Hyoscyamine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000658	0.000682	CcSEcCtD
Hyoscyamine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000656	0.00068	CcSEcCtD
Hyoscyamine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000649	0.000674	CcSEcCtD
Hyoscyamine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000646	0.000671	CcSEcCtD
Hyoscyamine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.00064	0.000664	CcSEcCtD
Hyoscyamine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000637	0.000661	CcSEcCtD
Hyoscyamine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000637	0.000661	CcSEcCtD
Hyoscyamine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000631	0.000654	CcSEcCtD
Hyoscyamine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.00063	0.000653	CcSEcCtD
Hyoscyamine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000627	0.000651	CcSEcCtD
Hyoscyamine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000625	0.000649	CcSEcCtD
Hyoscyamine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000625	0.000648	CcSEcCtD
Hyoscyamine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000623	0.000647	CcSEcCtD
Hyoscyamine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000622	0.000646	CcSEcCtD
Hyoscyamine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000621	0.000645	CcSEcCtD
Hyoscyamine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000621	0.000644	CcSEcCtD
Hyoscyamine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000606	0.000629	CcSEcCtD
Hyoscyamine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000603	0.000626	CcSEcCtD
Hyoscyamine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.0006	0.000623	CcSEcCtD
Hyoscyamine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000598	0.000621	CcSEcCtD
Hyoscyamine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000598	0.00062	CcSEcCtD
Hyoscyamine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000598	0.00062	CcSEcCtD
Hyoscyamine—CHRM4—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000595	0.0165	CbGpPWpGaD
Hyoscyamine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000594	0.000617	CcSEcCtD
Hyoscyamine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000594	0.000616	CcSEcCtD
Hyoscyamine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000589	0.000611	CcSEcCtD
Hyoscyamine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.00058	0.000602	CcSEcCtD
Hyoscyamine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000578	0.0006	CcSEcCtD
Hyoscyamine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000578	0.000599	CcSEcCtD
Hyoscyamine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.00057	0.000591	CcSEcCtD
Hyoscyamine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000564	0.000585	CcSEcCtD
Hyoscyamine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000558	0.000579	CcSEcCtD
Hyoscyamine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000558	0.000579	CcSEcCtD
Hyoscyamine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000553	0.000574	CcSEcCtD
Hyoscyamine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000553	0.000573	CcSEcCtD
Hyoscyamine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000551	0.000572	CcSEcCtD
Hyoscyamine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00055	0.00057	CcSEcCtD
Hyoscyamine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000537	0.000557	CcSEcCtD
Hyoscyamine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000533	0.000553	CcSEcCtD
Hyoscyamine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000532	0.000552	CcSEcCtD
Hyoscyamine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000532	0.000552	CcSEcCtD
Hyoscyamine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000529	0.000549	CcSEcCtD
Hyoscyamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000527	0.0146	CbGpPWpGaD
Hyoscyamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000525	0.0145	CbGpPWpGaD
Hyoscyamine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000521	0.000541	CcSEcCtD
Hyoscyamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00052	0.0144	CbGpPWpGaD
Hyoscyamine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000512	0.000531	CcSEcCtD
Hyoscyamine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000508	0.000527	CcSEcCtD
Hyoscyamine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000508	0.000527	CcSEcCtD
Hyoscyamine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000505	0.000524	CcSEcCtD
Hyoscyamine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000502	0.00052	CcSEcCtD
Hyoscyamine—CHRM1—Regulation of Actin Cytoskeleton—ACTG1—acquired immunodeficiency syndrome	0.000501	0.0139	CbGpPWpGaD
Hyoscyamine—CHRM3—Regulation of Actin Cytoskeleton—ACTG1—acquired immunodeficiency syndrome	0.0005	0.0138	CbGpPWpGaD
Hyoscyamine—CHRM2—Regulation of Actin Cytoskeleton—ACTG1—acquired immunodeficiency syndrome	0.000495	0.0137	CbGpPWpGaD
Hyoscyamine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000479	0.000496	CcSEcCtD
Hyoscyamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000473	0.0131	CbGpPWpGaD
Hyoscyamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000428	0.0119	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000401	0.0111	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.0004	0.0111	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000396	0.011	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00036	0.00998	CbGpPWpGaD
Hyoscyamine—CHRM4—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000333	0.00921	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000326	0.00903	CbGpPWpGaD
Hyoscyamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000319	0.00884	CbGpPWpGaD
Hyoscyamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000318	0.00881	CbGpPWpGaD
Hyoscyamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000315	0.00872	CbGpPWpGaD
Hyoscyamine—CHRM4—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000313	0.00866	CbGpPWpGaD
Hyoscyamine—CHRM4—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000313	0.00866	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000309	0.00855	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCRs, Other—CCR5—acquired immunodeficiency syndrome	0.000308	0.00852	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000305	0.00846	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCRs, Other—CCR5—acquired immunodeficiency syndrome	0.000305	0.00844	CbGpPWpGaD
Hyoscyamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000292	0.0081	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00029	0.00804	CbGpPWpGaD
Hyoscyamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000289	0.00799	CbGpPWpGaD
Hyoscyamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000288	0.00797	CbGpPWpGaD
Hyoscyamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000285	0.00789	CbGpPWpGaD
Hyoscyamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000264	0.00732	CbGpPWpGaD
Hyoscyamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000249	0.00689	CbGpPWpGaD
Hyoscyamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000249	0.00689	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000243	0.00673	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000242	0.00671	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00024	0.00664	CbGpPWpGaD
Hyoscyamine—CHRM4—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000238	0.00659	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000223	0.00617	CbGpPWpGaD
Hyoscyamine—CHRM2—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000221	0.00613	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00022	0.00609	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000219	0.00607	CbGpPWpGaD
Hyoscyamine—CHRM2—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	0.000219	0.00606	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000217	0.00601	CbGpPWpGaD
Hyoscyamine—CHRM4—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000214	0.00594	CbGpPWpGaD
Hyoscyamine—CHRM2—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000208	0.00576	CbGpPWpGaD
Hyoscyamine—CHRM2—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000208	0.00576	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000208	0.00576	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000207	0.00575	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000206	0.0057	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000205	0.00569	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000205	0.00568	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000203	0.00563	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000201	0.00558	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000199	0.00551	CbGpPWpGaD
Hyoscyamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000197	0.00546	CbGpPWpGaD
Hyoscyamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000197	0.00544	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000196	0.00542	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000195	0.0054	CbGpPWpGaD
Hyoscyamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000195	0.00539	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000193	0.00535	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000189	0.00524	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000189	0.00524	CbGpPWpGaD
Hyoscyamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000189	0.00524	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000185	0.00512	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00018	0.00499	CbGpPWpGaD
Hyoscyamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000178	0.00494	CbGpPWpGaD
Hyoscyamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000178	0.00492	CbGpPWpGaD
Hyoscyamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000176	0.00487	CbGpPWpGaD
Hyoscyamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00017	0.00472	CbGpPWpGaD
Hyoscyamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000168	0.00464	CbGpPWpGaD
Hyoscyamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000168	0.00464	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000167	0.00463	CbGpPWpGaD
Hyoscyamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000167	0.00463	CbGpPWpGaD
Hyoscyamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000167	0.00463	CbGpPWpGaD
Hyoscyamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000166	0.00458	CbGpPWpGaD
Hyoscyamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000166	0.00458	CbGpPWpGaD
Hyoscyamine—CHRM2—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000158	0.00439	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00015	0.00416	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00015	0.00414	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000148	0.0041	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000144	0.00399	CbGpPWpGaD
Hyoscyamine—CHRM2—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000143	0.00395	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000136	0.00376	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000135	0.00375	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000134	0.00371	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000134	0.00371	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000134	0.0037	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000132	0.00367	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00013	0.00359	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—TAT—acquired immunodeficiency syndrome	0.000129	0.00358	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000128	0.00354	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000128	0.00354	CbGpPWpGaD
Hyoscyamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000128	0.00353	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000127	0.00352	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000127	0.00352	CbGpPWpGaD
Hyoscyamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000127	0.00352	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000126	0.00349	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000126	0.00349	CbGpPWpGaD
Hyoscyamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000126	0.00349	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000125	0.00345	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000124	0.00344	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000123	0.00341	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000122	0.00337	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000121	0.00336	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00012	0.00332	CbGpPWpGaD
Hyoscyamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000115	0.00318	CbGpPWpGaD
Hyoscyamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000115	0.00317	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000114	0.00316	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000114	0.00315	CbGpPWpGaD
Hyoscyamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000113	0.00314	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000113	0.00312	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000112	0.00311	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000111	0.00308	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—AGPS—acquired immunodeficiency syndrome	0.00011	0.00304	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000109	0.00303	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000109	0.00303	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000107	0.00296	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000107	0.00296	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000103	0.00286	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	9.88e-05	0.00274	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	9.72e-05	0.00269	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	9.72e-05	0.00269	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	9.71e-05	0.00269	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	9.68e-05	0.00268	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	9.59e-05	0.00266	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	8.75e-05	0.00242	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	8.72e-05	0.00242	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	8.64e-05	0.00239	CbGpPWpGaD
Hyoscyamine—CHRM2—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	8.33e-05	0.00231	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	8.14e-05	0.00225	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	8.02e-05	0.00222	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	7.71e-05	0.00213	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	7.68e-05	0.00213	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	7.67e-05	0.00213	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	7.65e-05	0.00212	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	7.61e-05	0.00211	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	7.58e-05	0.0021	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	7.39e-05	0.00205	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	7.37e-05	0.00204	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	7.37e-05	0.00204	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	7.34e-05	0.00203	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	7.34e-05	0.00203	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	7.33e-05	0.00203	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	7.28e-05	0.00202	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	7.27e-05	0.00201	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	7.27e-05	0.00201	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	7.22e-05	0.002	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	7.22e-05	0.002	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	7.19e-05	0.00199	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	7.19e-05	0.00199	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	7.12e-05	0.00197	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	7.12e-05	0.00197	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	6.97e-05	0.00193	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	6.95e-05	0.00192	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	6.88e-05	0.00191	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	6.75e-05	0.00187	CbGpPWpGaD
Hyoscyamine—CHRM2—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	6.72e-05	0.00186	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	6.66e-05	0.00185	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	6.66e-05	0.00184	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	6.64e-05	0.00184	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	6.58e-05	0.00182	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	6.55e-05	0.00181	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	6.55e-05	0.00181	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	6.53e-05	0.00181	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	6.53e-05	0.00181	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	6.47e-05	0.00179	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	6.47e-05	0.00179	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	6.11e-05	0.00169	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	5.74e-05	0.00159	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	5.74e-05	0.00159	CbGpPWpGaD
Hyoscyamine—CHRM1—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	5.56e-05	0.00154	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	5.49e-05	0.00152	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	5.47e-05	0.00152	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	5.42e-05	0.0015	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	5.41e-05	0.0015	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	5.39e-05	0.00149	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	5.34e-05	0.00148	CbGpPWpGaD
Hyoscyamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	5.27e-05	0.00146	CbGpPWpGaD
Hyoscyamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	5.25e-05	0.00145	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	4.98e-05	0.00138	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	4.97e-05	0.00138	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	4.95e-05	0.00137	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	4.93e-05	0.00137	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	4.92e-05	0.00136	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	4.91e-05	0.00136	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	4.89e-05	0.00136	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	4.88e-05	0.00135	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	4.85e-05	0.00134	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	4.55e-05	0.00126	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	4.54e-05	0.00126	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	4.49e-05	0.00124	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	4.49e-05	0.00124	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	4.48e-05	0.00124	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	4.43e-05	0.00123	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	4.37e-05	0.00121	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	4.3e-05	0.00119	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	4.24e-05	0.00117	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	4.12e-05	0.00114	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	4.1e-05	0.00114	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	4.06e-05	0.00113	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	3.93e-05	0.00109	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.87e-05	0.00107	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.87e-05	0.00107	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.86e-05	0.00107	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.86e-05	0.00107	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	3.85e-05	0.00107	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.82e-05	0.00106	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.82e-05	0.00106	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.94e-05	0.000815	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.94e-05	0.000813	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.91e-05	0.000805	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.9e-05	0.000803	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.89e-05	0.000801	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.86e-05	0.000793	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.86e-05	0.000791	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.85e-05	0.000789	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.82e-05	0.000781	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.65e-05	0.000735	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.64e-05	0.000732	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.62e-05	0.000725	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.59e-05	0.000719	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.59e-05	0.000716	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.56e-05	0.000709	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.27e-05	0.000629	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.26e-05	0.000626	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—ALB—acquired immunodeficiency syndrome	2.25e-05	0.000624	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.53e-05	0.000424	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.53e-05	0.000423	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.53e-05	0.000422	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.52e-05	0.000421	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.51e-05	0.000419	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.51e-05	0.000417	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.34e-05	0.00037	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	9.01e-06	0.000249	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	8.98e-06	0.000249	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	8.89e-06	0.000246	CbGpPWpGaD
